z-logo
open-access-imgOpen Access
Pharmacogenetic testing for CYP2C19 gene polymorphism for optimization of using antiplatelet therapy in patients with ischemic heart disease
Author(s) -
Olena Karpenko
Publication year - 2016
Publication title -
sciencerise. medical science
Language(s) - English
Resource type - Journals
eISSN - 2519-4798
pISSN - 2519-478X
DOI - 10.15587/2519-4798.2016.76377
Subject(s) - cyp2c19 , clopidogrel , genotype , medicine , allele , gene polymorphism , gastroenterology , polymorphism (computer science) , aspirin , myocardial infarction , coronary artery disease , pharmacogenetics , platelet , pharmacology , gene , genetics , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here